The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Volkova E.N.

N.I. Pirogov Russian State Medical University

Lange D.A.

State Educational Institution of Higher Professional Education "Russian State Medical University"

Rodina Iu.A.

State Educational Institution of Higher Professional Education "Russian State Medical University"

Tarasova M.V.

State Educational Institution of Higher Professional Education "Russian State Medical University"

The use of methylprednisolone aceponate in the combined treatment of chronic dermatoses: analysis of erroneous applications

Authors:

Volkova E.N., Lange D.A., Rodina Iu.A., Tarasova M.V.

More about the authors

Read: 5619 times


To cite this article:

Volkova EN, Lange DA, Rodina IuA, Tarasova MV. The use of methylprednisolone aceponate in the combined treatment of chronic dermatoses: analysis of erroneous applications. Russian Journal of Clinical Dermatology and Venereology. 2010;8(5):97‑102. (In Russ.)

Recommended articles:
Search of diagnostic and prognostic biomarkers of immu­noinflammatory dermatoses by means of flow cyto­metry. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):170-177
Nucleotide sequence variants in IL4 and TNFA genes in patients with dermatoses and xero­sis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):178-184
Asse­ssment of the serum inte­rleukin 33 (IL-33) level in patients with atopic dermatitis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):293-296
Gene­sis of emollients. Past, present, future. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):412-420
From atopy to infe­ction — a clinical case of combined skin pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):430-436
Costs of home-based respiratory support and oxygen therapy. Medi­cal Technologies. Asse­ssment and Choice. 2025;(3):93-102
Mechanisms of addi­tivity of physiotherapeutic factors in complex therapy of poly­pous rhinosinusitis complicated by como­rbidities. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(3):5-11
Resu­lts of manual therapy in dege­nerative spine diseases with and without radi­culopathy. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(4):47-55

References:

  1. Belousova T.A., Lukashova N.N. Differentsirovannyi podkhod k vyboru naruzhnykh glyukokortikosteroidov v terapii dermatozov. Klin dermatol i venerol 2006;3:74-78.
  2. Kokhan M.M. Effektivnost' sochetannogo primeneniya naruzhnykh sredstv terapii i uvlazhneniya kozhi u bol'nykh atopicheskim dermatitom. Vestn dermatol i venerol 2007;4:55-60.
  3. Rutsika T., Tsaumzel' R.P. Effektivnost' i perenosimost' metilprednizolona atseponata ("Advantana") pri lechenii allergicheskikh dermatozov s porazheniem litsa. Klin dermatol i venerol 2003;2:68-73.
  4. Mashkilleison A.L., Gomberg M.A., Borisenko K.K. Opyt pri­meneniya "Advantana" u bol'nykh dermatozami. Vestn dermatol i venerol 1997;6:35-41.
  5. Fritsch P. Clinical experience with methylprednisolone aceponate in eczema. J. Dermatol Treat 1992;3:Suppl 2:17-19.
  6. Kochergin N.G., Belousova T.A. K voprosu o mestnoi kortikosteroidnoi terapii. Ros zhurn kozh i ven bol 2001;2:28-31.
  7. Luger T.A. Topische Dermatotherapie mit Glukokortikoiden - Therapeutischer index. Leitlinie der Deutschen Dermatologischen Gesellschaft 2004;7:629-634.
  8. Mori M., Pimpinelli N., Gianotti B. Topical corticosteroids and unwanted local effects: improving the benefit/risk ratio. Drug Safety 1994;10:5:406-412.
  9. Khamaganova I.V. "Advantan" v lechenii kontaktnykh allergicheskikh dermatozov, obuslovlennykh primeneniem sredstv dekorativnoi kosmetiki. Vestn dermatol i venerol 2005;5:58-59.
  10. Topicheskie steroidy. "Advantan". Informatsiya o preparate. M 2001.
  11. Meffert H., Schuppler J. Methylprednisolone aceponate lotion for treatment of acute eczema. Zeitschrift fur Hautkrankheiten 1999;74:88-94.
  12. Zaumseil R.P., Fuhrman H. et al. Methylprednisolone aceponate (Advantan) - an effective topical corticoid therapy with few side effects. Jabrbuch der Dermatologie 1992;3:247-263.
  13. Ruzicka T. Methylprednisolone aceponate in eczema and other inflammatory skin disorders - a clinical update. Int J Clin Pract 2006;60:1:85-92.
  14. Mensing H., Lorenz B. Experience with methylprednisolone aceponate in patients suffering from acute and chronic eczema. Results of a large observational study. Z Hautkr 1998;73:281-285.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.